Therefore, pSTAT5 promotes early lesion progression to cancer in both nulliparous and parous mice, and chemoprevention targeting Jak2/pSTAT5 may lower the risk of breast cancer in both nulliparous and parous women. This evidence concerns the gene JAK2 and cancer.